The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.

Korean Journal of Internal Medicine, ISSN 1226-3303, E-ISSN 2005-6648, published by the Korean Association of Internal Medicine, stands as a vital resource in the field of internal medicine. Since its inception in 1961 and the shift to open access in 1986, this journal has consistently provided a platform for innovative research and clinical practices, contributing significantly to the advancement of medical knowledge in South Korea and beyond. With an impressive 2023 impact factor and a Q2 quartile ranking among internal medicine journals, it occupies a commendable position in Scopus rankings, holding the #54 slot out of 167 in the category. The journal emphasizes the dissemination of high-quality research findings, clinical reviews, and case reports, making it indispensable for researchers, professionals, and students eager to stay at the forefront of internal medicine. For authors and readers alike, the journal fosters an engaged and informed community, supporting the continuing education and professional development necessary in today's rapidly evolving medical landscape.

The European Thyroid Journal, published by BIOSCIENTIFICA LTD, is a premier open-access journal that has been delivering high-quality research in the field of endocrinology since its inception. With an ISSN of 2235-0640 and an E-ISSN of 2235-0802, this journal serves as a vital resource for researchers, clinicians, and students focused on the latest developments in thyroid disease, diagnosis, and treatment. Located in Switzerland and currently enjoying a Q2 ranking in the Endocrinology, Diabetes, and Metabolism category for 2023, it ranks an impressive 71st out of 244 journals in its field, underscoring its significant impact, as evidenced by its substantial impact factor. The journal’s commitment to open access since 2022 enhances its accessibility and reach, ensuring that groundbreaking findings are disseminated swiftly and widely. By bridging knowledge across the endocrine research community, the European Thyroid Journal plays an instrumental role in advancing the understanding and management of thyroid-related disorders, making it an invaluable asset for anyone involved in this critical area of health.

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

Molecular Diagnosis & Therapy, published by ADIS INT LTD, is a premier journal dedicated to the cutting-edge fields of genetics, molecular medicine, and pharmacology. With a strong emphasis on the translation of molecular insights into innovative therapeutic strategies, this journal serves as a vital resource for researchers, clinicians, and students aiming to stay at the forefront of medical and scientific advancements. The journal boasts an impressive standing in its categories, holding a Q1 ranking in Genetics, Medicine (miscellaneous), and Pharmacology, alongside a Q2 classification in Molecular Medicine for 2023, reflecting its influential contributions to the scientific community. Indexed in Scopus, it occupies distinct positions in its respective fields, ranked #77 in Genetics and Pharmacology, and #53 in Molecular Medicine, highlighting its robust impact factor and scholarly influence. Although it is not open access, the journal ensures widespread dissemination of valuable research, promoting enhanced understanding of molecular diagnostic techniques and therapeutic interventions. Since its inception in 2001, and continuing through to 2024, Molecular Diagnosis & Therapy remains an essential platform for disseminating vital research findings, fostering academic collaboration, and driving forward the dialogue in molecular diagnostics and treatment methodologies.

GASTROINTESTINAL ENDOSCOPY, published by MOSBY-ELSEVIER, stands as a leading journal in the fields of gastroenterology and radiology, boasting an impressive impact factor that reflects its esteemed position within the academic community. Established in 1965 and set to continue through 2024, this journal is critical for disseminating high-quality research that informs clinical practice and enhances patient care. With a robust Scopus ranking — 25th out of 333 in Radiology, Nuclear Medicine and Imaging, and 15th out of 167 in Gastroenterology — it proudly maintains a #1 quartile status in both disciplines as of 2023. While the journal does not offer open access, it remains invaluable for researchers, professionals, and students seeking to stay ahead in the rapidly evolving fields of gastrointestinal pathology and innovative endoscopic procedures. Its comprehensive scope encompasses technological advancements, clinical studies, and critical reviews, making it a vital resource for advancing knowledge and supporting professional development.

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

Journal of Pancreatology, published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Endocrinology, Diabetes and Metabolism, and Hepatology. This Open Access journal, established to disseminate cutting-edge research and advancements in pancreatic health, has witnessed a substantial rise since its inception in 2018, with converged publications spanning through 2024. Although currently ranked in the Q3 category across multiple disciplines, the journal continually seeks to elevate the discourse around pancreatic diseases and endocrine functions through high-quality articles and comprehensive studies. Researchers, professionals, and students alike will find valuable insights that can drive future investigations and clinical applications. The journal is accessible from anywhere in the world, ensuring that critical knowledge in this important field reaches a wide audience without barriers. Explore the Journal of Pancreatology to stay at the forefront of pancreatic research and contribute to meaningful developments in medical science.

The International Journal of Cancer Management is a distinguished publication dedicated to advancing knowledge and research in the fields of cancer management, oncology, pharmacology, and radiology. Published by BRIEFLAND in the Netherlands, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in cancer care and treatment strategies. With an ISSN of 2538-4422 and an E-ISSN of 2538-497X, the journal features a range of peer-reviewed articles that cover diverse aspects of cancer management, reflecting its commitment to high-quality, impactful research. The journal ranks in the Q4 category for Cancer Research and Oncology and Q3 for both Pharmacology and Surgery in 2023, signifying its growing influence in the scientific community. Through its open access format, the International Journal of Cancer Management ensures that critical research findings are accessible to all, promoting collaboration and innovation in the battle against cancer. Researchers looking to share their findings or learn more about current trends will find this journal an invaluable addition to their professional toolkit.